CLASS I Drug recall · Reported 16 May 2018 · FDA Enforcement Report

Ampicillin and Sulbactam for Injection, USP*s/vial recalled

AuroMedics Pharma is recalling Ampicillin and Sulbactam for Injection, USP*s/vial, For Intramuscular or Intravenous Use, distributed nationwide in the US. The recall was initiated on 1 May 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: AS0317041-A, AS0317035-A; Exp August 2019
NDC55150-116, 55150-117, 55150-178, 55150-179
UPC0355150116201, 0355150179992, 0355150178995, 0355150117208
Quantity recalled54,720 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0866-2018
FDA event ID
79996
Recalling firm
AuroMedics Pharma, East Windsor, NJ
Manufacturer
Eugia US LLC
Classification
Class I
Status
Terminated
Recall initiated
1 May 2018
FDA classified
14 Jun 2018
Reported
16 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

1 May 2018Recall initiated by company
16 May 2018Published in enforcement report+15 days
14 Jun 2018Classified by FDA+29 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.

Product as listed by the FDA

Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.

Where it was distributed

Nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.

Which lots are affected?

Lot #: AS0317041-A, AS0317035-A; Exp August 2019

Where was it sold?

Nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from AuroMedics Pharma

All 36

Other Ampicillin recalls

All 31